Type P tumors and microacinar carcinomas constitutively express myoepithelial markers, whereas expression of these markers is an indicator of progression in Myc-, Hras-, and SV40-TAg-induced carcinomas, as it is in some types of human breast cancer [4,15,41]. This evidence concerns the gene MYC and carcinoma.